Phase II High-Dose Cyclophosphamide for Multiple Sclerosis

NCT00296205 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
25
Enrollment
OTHER
Sponsor class

Stopped I am changing locations to Johns Hopkins Medical Center

Conditions

Interventions

Sponsor

Stony Brook University